explore -WSS

explore

author：focus 2025-08-25 08:47:04 - browse：69

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Key Senate panel to consider PBM, drug pricing reform package

focus

knowledge

WSS

Live blog: Hearing on CRISPR

Moderna says combo Covid

Study: Why relieving medical debt did not improve financial outcomes

Health care court cases: Humana, Sutter, Novant

'Essentially witchcraft:' A former naturopath takes on the field

Cigna wins case to block Amy Bricker's move to CVS

entertainment

explore

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medical device trials still don't enroll enough women, study finds

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

What does generative AI mean for health care? We asked experts

Curing rare childhood diseases will falter unless Congress steps up

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Humans aren't the only ones with an imagination. Rats have it too

Alkermes shareholders re

Kidney transplant patients stopped immunosuppressants in trial

hotspot

The health care issue Democrats can’t solve: hospital reform

Kidney transplant patients stopped immunosuppressants in trial

Readers discuss the intersection of pregnancy and addiction

Medicare must police algorithms in Medicare Advantage, Dems say

Cigna wins case to block Amy Bricker's move to CVS

Medicare must police algorithms in Medicare Advantage, Dems say

leisure time

focus

knowledge

focus